Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions

Molecular Immunology

Volumn 44, Issue 1-3, 2007, Pages 33-43

  Bohlson, Suzanne S ^a   Fraser, Deborah A ^a   Tenner, Andrea J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptotic cells; C1q; Complement; Cytokine; Phagocytosis

Indexed keywords

C1Q GLOBULAR HEAD BINDING PROTEIN; CALRETICULIN; COLLAGEN RECEPTOR; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3B RECEPTOR; MANNOSE BINDING LECTIN; PROTEIN; SIGNAL REGULATORY PROTEIN ALPHA; SPR210 PROTEIN; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL INTERACTION; CYTOKINE PRODUCTION; GENE EXPRESSION; GENETIC DISORDER; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNITY; INFLAMMATION; INNATE IMMUNITY; MOLECULAR RECOGNITION; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MOTIF; REVIEW; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE REPAIR;

ANIMALS; ANTIGENS, CD; CALRETICULIN; COLLAGEN; COMPLEMENT C1Q; CYTOKINES; HUMANS; IMMUNITY, NATURAL; MANNOSE-BINDING LECTIN; PHAGOCYTOSIS; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION;

EID: 33750491279     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.06.021     Document Type: Review

References (116)

1. Aderem A., and Underhill D.M. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17 (1999) 593-623
2. Alcorn J.F., and Wright J.R. Surfactant protein A inhibits alveolar macrophage cytokine production by a C. Am. J. Physiol Lung Cell. Mol. Physiol. (2003)
3. Arnett H.A., Wang Y., Matsushima G.K., Suzuki K., and Ting J.P. Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration. J. Neurosci. 23 (2003) 9824-9832
4. Arora M., Munoz E., and Tenner A.J. Identification of a site on Mannan-binding lectin critical for enhancement of phagocytosis. J. Biol. Chem. 276 (2001) 43087-43094
5. Aubert B., Chesne S., Arlaud G.J., and Colomb M.G. Antibody-independent interaction between the first component of human complement, C1, and the outer membrane of Escherichia coli D31 m4. Biochem. J. 232 (1985) 513-519
6. Beningo K.A., and Wang Y.L. Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target. J. Cell. Sci. 115 (2002) 849-856
7. Bensa J.C., Reboul A., and Colomb M.G. Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes. Biochem. J. 216 (1983) 385-392
8. Blander J.M., and Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature (2006)
9. Bobak D.A., Frank M.M., and Tenner A.J. C1q acts synergistically with phorbol dibutyrate to activate CR1-mediated phagocytosis by human mononuclear phagocytes. Eur. J. Immunol. 18 (1988) 2001-2007
10. Bobak D.A., Gaither T.G., Frank M.M., and Tenner A.J. Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages. J. Immunol. 138 (1987) 1150-1156
11. Bohuslav J., Kravchenko V.V., Parry G.C., Erlich J.H., Gerondakis S., Mackman N., and Ulevitch R.J. Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. J. Clin. Invest. 102 (1998) 1645-1652
12. Borron P., McCormack F.X., Elhalwagi B.M., Chroneos Z.C., Lewis J.F., Zhu S., Wright J.R., Shepherd V.L., Possmayer F., Inchley K., and Fraher L.J. Surfactant protein A inhibits T cell proliferation via its collagen-like tail and a 210-kDa receptor. Am. J. Physiol. Lung Cell. Mol. Physiol. 275 (1998) L679-L686
13. Botto M., Dell'agnola C., Bygrave A.E., Thompson E.M., Cook H.T., Petry F., Loos M., Pandolfi P.P., and Wai port M.J. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19 (1998) 56-59
14. Botto M., and Walport M.J. C1q, autoimmunity and apoptosis. Immunobiology 205 (2002) 395-406
15. Butko P., Nicholson-Weller A., and Wessels M.R. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus. J. Immunol. 163 (1999) 2761-2768
16. Bygrave A.E., Rose K.L., Cortes-Hernandez J., Warren J., Rigby R.J., Cook H.T., Walport M.J., Vyse T.J., and Botto M. Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol. 2 (2004) E243
17. Castellano F., Chavrier P., and Caron E. Actin dynamics during phagocytosis. Semin. Immunol. 13 (2001) 347-355
18. Chroneos Z.C., Abdolrasulnia R., Whitsett J.A., Rice W.R., and Shepherd V.L. Purification of a cell-surface receptor for surfactant protein A. J. Biol. Chem. 271 (1996) 16375-16383
19. Dedio J., Jahnen-Dechent W., Bachmann M., and Müller-Esterl W. The multiligand-binding protein gC1qR, putative Clq receptor, is a mitochondrial protein. J. Immunol. 160 (1998) 3534-3542
20. Dierich M.P., Ebenbichler C.F., Marschang P., Fust G., Thielens N.M., and Arlaud G.J. HIV and human complement: mechanisms of interaction and biological implication. Immunol. Today 14 (1993) 435-440
21. Dietzschold B., Schwaeble W., Schäfer M.K.H., Hooper D.C., Zehng Y.M., Petry F., Sheng H., Fink T., Loos M., Koprowski H., and Weihe E. Expression of C1q, a subcomponent of the rat complement system, is dramatically enhanced in brains of rats with either Borna disease or experimental allergic encephalomyelitis. J. Neurol. Sci. 130 (1995) 11-16
22. Donnelly S., Roake W., Brown S., Young P., Naik H., Wordsworth P., Isenberg D.A., Reid K.B., and Eggleton P. Impaired recognition of apoptotic neutrophils by the C1q/calreticulin and CD91 pathway in systemic lupus erythematosus. Arthritis Rheum. 54 (2006) 1543-1556
23. Edelson B.T., Stricker T.P., Li Z., Dickeson S.K., Shepherd V.L., Santoro S.A., and Zutter M.M. Novel collectin/C1q receptor mediates mast cell activation and innate immunity. Blood 107 (2006) 143-150
24. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., and Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101 (1998) 890-898
25. Fan R., and Tenner A.J. Complement C1q expression induced by Abeta in rat hippocampal organotypic slice cultures. Exp. Neurol. 185 (2004) 241-253
26. Fraser D.A., Bohlson S.S., Jasinskiene N., Rawal N., Palmarini G., Ruiz S., Rochford R., and Tenner A.J. C1q and MBL, components of the innate immune system, influence monocyte cytokine expression. J. Leukoc. Biol. (2006)
27. Gardai S.J., Xiao Y.Q., Dickinson M., Nick J.A., Voelker D.R., Greene K.E., and Henson P.M. By binding SIRPalpha orcalreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115 (2003) 13-23
28. Garred P., Larsen F., Seyfarth J., Fujita R., and Madsen H.O. Mannose-binding lectin and its genetic variants. Genes Immun. 7 (2006) 85-94
29. Garred P., Voss A., Madsen H.O., and Junker P. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun. 2 (2001) 442-450
30. Ghebrehiwet B., Lim B.-L., Peerschke E.I.B., Willis A.C., and Reid K.B.M. Isolation, cDNA cloning, and overexpression of a 33-kDa cell surface glycoprotein that binds to the globular "heads" ofC1q. J. Exp. Med. 179 (1994) 1809-1821
31. Ghiran L., Barbashov S.F., Klickstein L.B., Tas S.W., Jensenius J.C., and Nicholson-Weller A. Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J. Exp. Med. 192 (2000) 1797-1808
32. Ghiran L., Klickstein L.B., and Nicholson-Weller A. Calreticulin is at the surface of circulating neutrophils and uses CD59 as an adaptor molecule. J. Biol. Chem. 278 (2003) 21024-21031
33. Goldsmith S.K., Wals P., Rozovsky L., Morgan T.E., and Finch C.E. Kainicacid and decorticating lesions stimulate the synthesis of C1q protein in adult rat brain. J. Neurochem. 68 (1997) 2046-2052
34. Goodman E.B., Anderson D.C., and Tenner A.J. C1q triggers neutrophil superoxide production by a unique CD18-dependent mechanism. J. Leukoc. Biol. 58 (1995) 168-176
35. Goodman E.B., and Tenner A.J. Signal transduction mechanisms of C1q-mediated superoxide production: evidence for the involvement of temporally distinct stauosporine insensitive and sensitive pathways. J. Immunol. 148 (1992) 3920-3928
36. Gregory C.D. CD14-dependent clearance of apoptotic cells: relevance to the immune system. Curr. Opin. Immunol. 12 (2000) 27-34
37. Grimsley C., and Ravichandran K.S. Cues for apoptotic cell engulfment: eat-me, don't eat-me and come-get-me signals. Trends Cell. Biol. 13 (2003) 648-656
38. Guan E., Robinson S.L., Goodman E.B., and Tenner A.J. Cell surface protein identified on phagocytic cells modulates the C1q-mediated enhancement of phagocytosis. J. Immunol. 152 (1994) 4005-4016
39. Hanayama R., Tanaka M., Miyasaka K., Aozasa K., Koike M., Uchiyama Y., and Nagata S. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304 (2004) 1147-1150
40. Hoebe K., Janssen E., and Beutler B. The interface between innate and adaptive immunity. Nat. Immunol. 5 (2004) 971-974
41. Holmskov U., Thiel S., and Jensenius J.C. Collections and ficolins: humoral lectins of the innate immune defense. Annu. Rev. Immunol. 21 (2003) 547-578
42. Ip W.K., Chan S.Y., Lau C.S., and Lau Y.L. Association of systemic lupus erythematosus with promoter polymorphisms of the mannose-binding lectin gene. Arthritis Rheum. 41 (1998) 1663-1668
43. Isogawa Y., Kon T., Inoue T., Ohkura R., Yamakawa H., Ohara O., and Sutoh K. The N-terminal domain of MYO18A has an ATP-insensitive actin-binding site. Biochemistry 44 (2005) 6190-6196
44. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5 (2004) 987-995
45. Khalkhali-Ellis Z., Bulla G.A., Schlesinger L.S., Kirschmann D.A., Moore T.L., and Hendrix M.J. C1q-containing immune complexes purified from sera of juvenile rheumatoid arthritis patients mediate IL-8 production by human synoviocytes: role of C1q receptors. J. Immunol. 163 (1999) 4612-4620
46. Kim S., Elkon K.B., and Ma X. Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity 21 (2004) 643-653
47. Kim T.S., Park M., Nepomuceno R.R., Palmarini G., Winokur S., Cotman C.A., Bengtsson U., and Tenner A.J. Characterization of the murine homolog of C1qR(P): identical cellular expression pattern, chromosomal location and functional activity of the human and murine C1qR(P). Mol. Immunol. 37 (2000) 377-389
48. Klickstein L.B., Barbashov S.F., Liu T., Jack R.M., and Nicholson-Weller A. Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity 7 (1997) 345-355
49. Kodama T., Doi T., Suzuki H., Takahashi K., Wada Y., and Gordon S. Collagenous macrophage scavenger receptors. Curr. Opin. Lipidol. 7 (1996) 287-291
50. Kojouharova M.S., Tsacheva L.G., Tchorbadjieva M.I., Reid K.B., and Kishore U. Localization of ligand-binding sites on human C1q globular head region using recombinant globular head fragments and single-chain antibodies. Biochim. Biophys. Acta 1652 (2003) 64-74
51. Korb L.C., and Ahearn J.M. C1q binding directly and specifically to surface blebs of apoptotic human keratinocytes. J. Immunol. 158 (1997) 4525-4528
52. Kovacsovics T.J., Peitsch M.C., Kress A., and Isliker H. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles. J. Immunol. 138 (1987) 1864-1870
53. Krarup A., Thiel S., Hansen A., Fujita T., and Jensenius J.C. L-ficolin is a pattern recognition molecule specific for acetyl groups. J. Biol. Chem. (2004)
54. Krieger M. The other side of scavenger receptors: pattern recognition for host defense. Curr. Opin. Lipidol. 8 (1997) 275-280
55. Kunzmann S., Wright J.R., Steinhilber W., Kramer B.W., Blaser K., Speer C.P., and Schmidt-Weber C. TGF-{beta}1 in SP-A preparations influences immune suppressive properties of SP-A on human CD4+ T lymphocytes. Am. J. Physiol. Lung Cell. Mol. Physiol. (2006)
56. Lee C.K., Klopp R.G., Weindruch R., and Prolla T.A. Gene expression profile of aging and its retardation by caloric restriction. Science 285 (1999) 1390-1393
57. Lee C.K., Weindruch R., and Prolla T.A. Gene-expression profile of the ageing brain in mice. Nat. Genet. 25 (2000) 294-297
58. Leigh L.E., Ghebrehiwet B., Perera T.P., Bird I.N., Strong P., Kishore U., Reid K.B., and Eggleton P. C1q-mediated chemotaxis by human neutrophils: involvement of gClqR and G-protein signalling mechanisms. Biochem. J. 330 Pt 1 (1998) 247-254
59. Lu J., Tay P.N., Kon O.L., and Reid K.B. Human ficolin: cDNA cloning, demonstration of peripheral blood leucocytes as the major site of synthesis and assignment of the gene to chromosome 9. Biochem. J. 313 (1996) 473-478
60. Lucas M., Stuart L.M., Savill J., and Lacy-Hulbert A. Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion. J. Immunol. 171 (2003) 2610-2615
61. Matsushita M., and Fujita T. The role of ficolins in innate immunity. Immunobiology 205 (2002) 490-497
62. Medzhitov R., and Janeway Jr. C.A. Innate immune induction of the adaptive immune response. Cold Spring Harb. Symp. Quant. Biol. 64 (1999) 429-435
63. Mevorach D., Mascarenhas J.O., Gershov D., and Elkon K.B. Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 188 (1998) 2313-2320
64. Mitchell D.A., Pickering M.C., Warren J., Fossati-Jimack L., Cortes-Hernandez J., Cook H.T., Botto M., and Walport M.J. C1q deficiency and autoimmunity: the effects of genetic background on disease expression. J. Immunol. 168 (2002) 2538-2543
65. Miura-Shimura Y., Nakamura K., Ohtsuji M., Tomita H., Jiang Y., Abe M., Zhang D., Hamano Y., Tsuda H., Hashimoto H., Nishimura H., Taki S., Shirai T., and Hirose S. C1q regulatory region polymorphism down-regulating murine dq protein levels with linkage to lupus nephritis. J. Immunol. 169 (2002) 1334-1339
66. Nauta A.J., Castellano G., Xu W., Woltman A.M., Borrias M.C., Daha M.R., van Kooten C., and Roos A. Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells. J. Immunol. 173 (2004) 3044-3050
67. Nauta A.J., Roos A., and Daha M.R. A regulatory role for complement in innate immunity and autoimmunity. Int. Arch. Allergy Immunol. 134 (2004) 310-323
68. Navratil J.S., Korb L.C., and Ahearn J.M. Systemic lupus erythematosus and complement deficiency: clues to a novel role for the classical complement pathway in the maintenance of immune tolerance. Immunopharmacology 42 (1999) 47-52
69. Navratil J.S., Watkins S.C., Wisnieski J.J., and Ahearn J.M. The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells. J. Immunol. 166 (2001) 3231-3239
70. P, the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro. Immunity 6 (1997) 119-129
71. P is a heavily O-glycosylated cell surface protein involved in the regulation of phagocytic activity. J. Immunol. 162 (1999) 3583-3589
72. Norsworthy P.J., Fossati-Jimack L., Cortes-Hernandez J., Taylor P.R., Bygrave A.E., Thompson R.D., Nourshargh S., Wai port M.J., and Botto M. Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis. J. Immunol. 172 (2004) 3406-3414
73. Ogden C.A., deCathelineau A., Hoffmann P.R., Bratton D., Ghebrehiwet B., Fadok V.A., and Henson P.M. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194 (2001) 781-796
74. Otabor L., Tyagi S., Beurskens F.J., Ghiran L., Schwab P., Nicholson-Weller A., and Klickstein L.B. A role for lipid rafts in C1q-triggered 02- generation by human neutrophils. Mol. Immunol. 41 (2004) 185-190
75. Ouchi N., Kihara S., Arita Y., Okamoto Y., Maeda K., Kuriyama H., Hotta K., Nishida M., Takahashi M., Muraguchi M., Ohmoto Y., Nakamura T., Yamashita S., Funahashi T., and Matsuzawa Y. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102 (2000) 1296-1301
76. Park M. Characterization of Structural Parameters Critical for C1qRp, Receptor for C1q that Enhances Phagocytosis (2001), University of California, Irvine pp. 165-170, Ref. type: Thesis/Dissertation
77. Pickering M.C., Botto M., Taylor P.R., Lachmann P.J., and Walport M.J. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv. Immunol. 76 (2000) 227-324
78. Potter P.K., Cortes-Hernandez J., Quartier P., Botto M., and Walport M.J. Lupus-prone mice have an abnormal response to thioglycolate and an impaired clearance of apoptotic cells. J. Immunol. 170 (2003) 3223-3232
79. Reboul A., Prandini M.H., Bensa J.C., and Colomb M.G. Characterization of C1q, C1s and C1 Inh synthesized by stimulated human monocytes in vitro. FEBS Lett. 190 (1985) 65-68
80. Rimoldi M.T., Tenner A.J., Bobak D.A., and Joiner K.A. Complement component C1q enhances invasion of human mononuclear phagocytes and fibroblasts by Trypanosoma cruzi trypomastigotes. J. Clin. Invest. 84 (1989) 1982-1989
81. Roos A., Xu W., Castellano G., Nauta A.J., Garred P., Daha M.R., and van Kooten C. Mini-review: a pivotal role for innate immunity in the clearance of apoptotic cells. Eur. J. Immunol. 34 (2004) 921-929
82. Ruiz S., Henschen-Edman A.H., Nagase H., and Tenner A.J. Digestion of C1q collagen-like domain with MMPs-1, -2, -3, and -9 further defines the sequence involved in the stimulation of neutrophil superoxide production. J. Leukoc. Biol. 66 (1999) 416-422
83. Ruiz S., Henschen-Edman A.H., and Tenner A.J. Localization of the site on the complement component C1q required for the stimulation of neutrophil superoxide production. J. Biol. Chem. 270 (1995) 30627-30634
84. Sahu A., and Lambris J.D. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol. Rev. 180 (2001) 35-48
85. Savill J., and Fadok V. Corpse clearane defines the meaning of cell death. Nature 407 (2000) 784-788
86. Schagat T.L., Wofford J.A., and Wright J.R. Surfactant protein A enhances alveolar macrophage phagocytosis of apoptotic neutrophils. J. Immunol. 166 (2001) 2727-2733
87. Scherer P.E., Williams S., Fogliano M., Baldini G., and Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270 (1995) 26746-26749
88. Scott R.S., McMahon E.J., Pops S.M., Reap E.A., Caricchio R., Cohen P.L., Earp H.S., and Matsushima G.K. Phagocytosis and clearance of apoptotic cells is mediated by mer. Nature 411 (2001) 207-211
89. Spear G.T., Jiang H., Sullivan B.L., Gewurz H., Landay A.L., and Lint T.F. Direct binding of complement component C1q to Human Immunodeficiency Virus (HIV) and Human T Lymphotrophic Virus-I (HTLV-1) coinfected cells. AIDS Res. Hum. Retrov. 7 (1991) 579-585
90. Stamme C., Walsh E., and Wright J.R. Surfactant protein A differentially regulates IFN-gamma- and LPS-induced nitrite production by rat alveolar macrophages. Am. J. Respir. Cell. Mol. Biol. 23 (2000) 772-779
91. Steinberger P., Szekeres A., Wlle S., Stockl J., Selenko N., Prager E., Staffler G., Madic O., Stockinger H., and Knapp W. Identification of human CD93 as the phagocytic C1q receptor (C1qRp) by expression cloning. J. Leukoc. Biol. 71 (2002) 133-140
92. Stuart L.M., and Ezekowitz R.A. Phagocytosis: elegant complexity. Immunity 22 (2005) 539-550
93. Stuart L.M., Lucas M., Simpson C., Lamb J., Savill J., and Lacy-Hulbert A. Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J. Immunol. 168 (2002) 1627-1635
94. Stuart G.R., Lynch N.J., Day A.J., Schwaeble W.J., and Sim R.B. The C1q and collectin binding site within C1q receptor (cell surface calreticulin). Immunopharmacology 38 (1997) 73-80
95. Stuart L.M., Takahashi K., Shi L., Savill J., and Ezekowitz R.A. Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J. Immunol. 174 (2005) 3220-3226
96. Taylor P.R., Carugati A., Fadok V.A., Cook H.T., Andrews M., Carroll M.C., Savill J.S., Henson P.M., Botto M., and WalportM J. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. 192 (2000) 359-366
97. Tenner A.J. Membrane receptors for soluble defense collagens. Curr. Opin. Immunol. 11 (1999) 34-42
98. Tenner A.J., and Cooper N.R. Stimulation of a human polymorphonuclear leukocyte oxidative response by the C1q subunit of the first complement component. J. Immunol. 128 (1982) 2547-2552
99. Tenner A.J., Robinson S.L., Borchelt J., and Wright J.R. Human pulmonary surfactant protein (SP-A), a protein structurally homologous to C1q, can enhance FcR- and CR1-mediated phagocytosis. J. Biol. Chem. 264 (1989) 13923-13928
100. r component of the C1q receptor. Immunity 3 (1995) 485-493
101. Turner M.W. The role of mannose-binding lectin in health and disease. Mol. Immunol. 40 (2003) 423-429
102. Uhlenbruck G., Karduck D., Haupt H., and Schwick H.G. C-reactive protein (CRP), 9.5 salpha1-glycoprotein and C1q: serum proteins with lectin properties?. Z. Immunitatsforsch. Immunobiol. 155 (1979) 262
103. Vandivier R.W., Ogden C.A., Fadok V.A., Hoffmann P.R., Brown K.K., Botto M., Walport M.J., Fisher J.H., Henson P.M., and Greene K.E. Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J. Immunol. 169 (2002) 3978-3986
104. Vegh Z., Goyarts E.C., Rozengarten K., Mazumder A., and Ghebrehiwet B. Maturation-dependent expression of C1q binding proteins on the cell surface of human monocyte-derived dendritic cells. Int. Immunopharmacol. 3 (2003) 39-51
105. Vegh Z., Kew R.R., Gruber B.L., and Ghebrehiwet B. Chemotaxis of human monocyte-derived dendritic cells to complement component C1q is mediated by the receptors gC1qR and cC1qR. Mol. Immunol. 43 (2006) 1402-1407
106. Waggoner S.N., Cruise M.W., Kassel R., and Hahn Y.S. gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway. J. Immunol. 175 (2005) 4706-4714
107. Walport M.J. Complement and systemic lupus erythematosus. Arthritis Res. 4 Suppl. 3 (2002) S279-S293
108. Warren J., Botto M., Mastroeni P., Dougan G., Cohen J., and Walport M.J. Increased susceptibility of C1q and Bf/C2-deficient mice to Salmonella infection. Mol. Immunol. 35 (1998) 344 Ref. type: Abstract
109. Webster S.D., Galvan M.D., Ferran E., Garzon-Rodriguez W., Glabe C.G., and Tenner A.J. Antibody-mediated phagocytosis of the amyloid β-peptide in microglia is differentially modulated by C1q. J. Immunol. 166 (2001) 7496-7503
110. P, the C1q receptor that enhances phagocytosis. J. Leuk. Biol. 67 (2000) 109-116
111. Weikert L.F., Edwards K., Chroneos Z.C., Hager C., Hoffman L., and Shepherd V.L. SP-A enhances uptake of bacillus Calmette-Guerin by macrophages through a specific SP-A receptor. Am. J. Physiol.: Lung Cell. Mol. Physiol. 272 (1997) L989-L995 Ref. Type: Journal (Full)
112. Yamada M., Oritani K., Kaisho T., Ishikawa J., Yoshida H., Takahashi L., Kawamoto S., Ishida N., Ujiie H., Masaie H., Botto M., Tomiyama Y., and Matsuzawa Y. Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells. Eur. J. Immunol. 34 (2004) 221-230
113. Yamauchi T., Hara K., Kubota N., Terauchi Y., Tobe K., Froguel P., Nagai R., and Kadowaki T. Dual roles of adiponectin/Acrp30 in vivo as an anti-diabetic and anti-atherogenic adipokine. Curr. Drug Targets Immune. Endocr. Metabol. Disord. 3 (2003) 243-254
114. Yang C.H., Szeliga J., Jordan J., Faske S., Sever-Chroneos Z., Dorsett B., Christian R.E., Settlage R.E., Shabanowitz J., Hunt D.F., Whitsett J.A., and Chroneos Z.C. Identification of the surfactant protein A receptor 210 as the unconventional myosin 18A. J. Biol. Chem. 280 (2005) 34447-34457
115. Yao Z.Q., Waggoner S.N., Cruise M.W., Hall C., Xie X., Oldach D.W., and Hahn Y.S. SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function. J. Virol. 79 (2005) 15417-15429
116. Yarovinsky F., Zhang D., Andersen J.F., Bannenberg G.L., Serhan C.N., Hayden M.S., Hieny S., Sutterwala F.S., Flavell R.A., Ghosh S., and Sher A. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308 (2005) 1626-1629